Africa’s largest COVID-19 treatment clinical trial launched in 13 countries

Press ReleaseLeave a comment

Thirteen African countries and an international network of research institutions have joined forces to launch the largest COVID-19 clinical trial in mild-to-moderate outpatients in Africa. The ANTICOV clinical trial aims to respond to the urgent need to identify treatments that can be used to treat mild and moderate cases of COVID-19 early and prevent spikes…

A Landmark trial in East and Southern Africa finds injectable PrEP safe and effective for cisgender women

Press ReleaseLeave a comment

Regulatory review and introduction plans must be accelerated New York City, November 9, 2020— AVAC enthusiastically welcomes the news that another trial of the long-acting, injectable antiretroviral cabotegravir (CAB-LA) for HIV prevention for HIV pre-exposure prophylaxis (PrEP) has demonstrated safety and efficacy, this time among cisgender women. Today’s announcement from ViiV, the US National Institute of Allergy and…